Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker

Head and neck squamous cell carcinoma (HNSCC) is a potential curative disease at its localized stage, by the use of multimodal treatment including surgery, radiation, and chemotherapy. While the metastatic stage is considered incurable and is characterized by poor prognosis. Conventional cytotoxic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Oualla, Karima, Castelo Branco, Luis, Nouiyakh, Lamiae, Amaadour, Lamiae, Benbrahim, Zineb, Arifi, Samia, Mellas, Nawfel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Commentary & View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204468/
https://www.ncbi.nlm.nih.gov/pubmed/33827280
http://dx.doi.org/10.1177/10732748211004878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204468/
https://www.ncbi.nlm.nih.gov/pubmed/33827280
http://dx.doi.org/10.1177/10732748211004878

Ejemplares similares